Sabba Stephen L
SEC CIK 1442372 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | Dir | 35.8K | — | $1.80M | 15 | 2022-06-10 | 2026-06-16 |
Most active insiders at LGND, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Espinoza Octavio | CFO | — | $13.03M |
| 2 | Reardon Andrew | CLO, Sec | — | $8.77M |
| 3 | Haas Jason | Dir | — | $3.74M |
| 4 | LAMATTINA JOHN L | Dir | — | $2.44M |
| 5 | Gray Nancy Ryan | Dir | — | $1.35M |
| 6 | Aryeh Jason | Dir | — | $1.25M |
| 7 | KOZARICH JOHN W | Dir | — | $1.20M |
| 8 | Sabba Stephen L | Dir | — | $1.16M |
| 9 | Zimmermann Martine | Dir | — | $342.0K |
| 10 | Davis Todd C | CEO, Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-18 08:37 | 2026-06-16 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | M - OptEx | $66.13 | +2,145 | 35.8K | +6% | +$141.8K |
| D | 2026-06-18 08:37 | 2026-06-16 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | S - Sale+OE | $254.00 | -2,145 | 33.6K | -6% | -$544.8K |
| D | 2026-06-09 19:41 | 2026-06-05 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | A - Grant | $0.00 | +836 | 33.6K | +3% | $0 |
| 2026-03-25 | 2026-03-23 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | S - Sale | $207.87 | -1,000 | 32.8K | -3% | -$207.9K | |
| D | 2026-03-05 | 2026-03-03 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | M - OptEx | $69.51 | +2,034 | 35.8K | +6% | +$141.4K |
| D | 2026-03-05 | 2026-03-03 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | S - Sale+OE | $201.50 | -2,034 | 33.8K | -6% | -$409.9K |
| D | 2025-06-10 | 2025-06-06 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | A - Grant | $0.00 | +1,209 | 33.8K | +4% | $0 |
| D | 2025-04-16 | 2025-04-01 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | M - OptEx | $52.30 | +2,406 | 32.6K | +8% | +$125.8K |
| D | 2024-06-25 | 2024-06-14 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | A - Grant | $0.00 | +1,252 | 30.2K | +4% | $0 |
| D | 2024-03-07 | 2024-03-05 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | M - OptEx | $0.00 | +2,893 | 30.8K | +10% | $0 |
| D | 2024-03-07 | 2024-03-05 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | S - Sale+OE | $74.30 | -1,893 | 28.9K | -6% | -$140.6K |
| D | 2023-06-21 | 2023-06-09 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | A - Grant | $0.00 | +1,142 | 26.9K | +4% | $0 |
| D | 2023-05-12 | 2023-05-10 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | S - Sale+OE | $77.13 | -6,408 | 25.8K | -20% | -$494.2K |
| D | 2023-05-12 | 2023-05-10 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | M - OptEx | $0.00 | +6,408 | 32.2K | +25% | $0 |
| D | 2022-06-14 | 2022-06-10 | LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Dir | A - Grant | $0.00 | +1,004 | 26.1K | +4% | $0 |
Purchase Sale Sale after option exercise All abbreviations